C-terminal HERG mutations: the role of hypokalemia and a KCNQ1-associated mutation in cardiac event occurrence

Circulation. 1999 Mar 23;99(11):1464-70. doi: 10.1161/01.cir.99.11.1464.

Abstract

Background: The long-QT syndrome (LQTS) is a genetically heterogeneous disease in which 4 genes encoding ion-channel subunits have been identified. Most of the mutations have been determined in the transmembrane domains of the cardiac potassium channel genes KCNQ1 and HERG. In this study, we investigated the 3' part of HERG for mutations.

Methods and results: New specific primers allowed the amplification of the 3' part of HERG, the identification of 2 missense mutations, S818L and V822 M, in the putative cyclic nucleotide binding domain, and a 1-bp insertion, 3108+1G. Hypokalemia was a triggering factor for torsade de pointes in 2 of the probands of these families. Lastly, in a large family, a maternally inherited G to A transition was found in the splicing donor consensus site of HERG, 2592+1G-A, and a paternally inherited mutation, A341E, was identified in KCNQ1. The 2 more severely affected sisters bore both mutations.

Conclusions: The discovery of mutations in the C-terminal part of HERG emphasizes that this region plays a significant role in cardiac repolarization. Clinical data suggests that these mutations may be less malignant than mutations occurring in the pore region, but they can become clinically significant in cases of hypokalemia. The first description of 2 patients with double heterozygosity associated with a dramatic malignant phenotype implies that genetic analysis of severely affected young patients should include an investigation for >1 mutation in the LQT genes.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amino Acid Sequence
  • Amino Acid Substitution
  • Animals
  • Cation Transport Proteins*
  • Cattle
  • Child, Preschool
  • Consensus Sequence
  • DNA Mutational Analysis
  • DNA-Binding Proteins*
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • Heart / physiopathology
  • Humans
  • Hypokalemia / complications*
  • Hypokalemia / physiopathology
  • Ion Transport
  • KCNQ Potassium Channels
  • KCNQ1 Potassium Channel
  • Long QT Syndrome / complications
  • Long QT Syndrome / genetics*
  • Long QT Syndrome / physiopathology
  • Male
  • Membrane Potentials
  • Mice
  • Middle Aged
  • Molecular Sequence Data
  • Myocardium / metabolism
  • Pedigree
  • Point Mutation*
  • Polymorphism, Single-Stranded Conformational
  • Potassium Channels / genetics*
  • Potassium Channels, Voltage-Gated*
  • RNA Splicing
  • Sequence Alignment
  • Torsades de Pointes / etiology
  • Torsades de Pointes / genetics*
  • Torsades de Pointes / physiopathology
  • Trans-Activators*
  • Transcriptional Regulator ERG

Substances

  • Cation Transport Proteins
  • DNA-Binding Proteins
  • ERG protein, human
  • ERG1 Potassium Channel
  • Ether-A-Go-Go Potassium Channels
  • KCNH2 protein, human
  • KCNH6 protein, human
  • KCNQ Potassium Channels
  • KCNQ1 Potassium Channel
  • KCNQ1 protein, human
  • Kcnq1 protein, mouse
  • Potassium Channels
  • Potassium Channels, Voltage-Gated
  • Trans-Activators
  • Transcriptional Regulator ERG